Advertisement
News
Advertisement

CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys(2)

Fri, 12/10/2010 - 2:32pm
U.S. Food & Drug Administration
As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the first place.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading